1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Industry Market Research Reports 2022 - Europe

Chronic Disease Industry Market Research Reports 2022 - Europe

1-30 of about 1200 reports

Download Unlimited Documents from Trusted Public Sources

View report >

AlzeCure Pharma AB Analyst report

  • January 2022
  • 7 pages
  • Australia
  • Oceania
  • Chronic Pain
  • Dementia
  • Broker research
  • Company
  • Drug Approval
View report >

Galapagos Quarterly report

  • January 2022
  • 7 pages
  • Europe
  • World
  • Arthritis
  • Pharmaceutical
  • Quarterly report
  • Company
View report >

AstraZeneca Analyst report

  • January 2022
  • 15 pages
  • China
  • European Union
  • Infectious Disease
  • Vaccine
  • Broker research
  • Company
  • Drug Approval
View report >

Novo Nordisk Investor presentation

  • December 2021
  • 7 pages
  • United States
  • World
  • Obesity
  • Public Health
  • Investor presentation
  • Company
View report >

Novo Nordisk Analyst report

  • December 2021
  • 36 pages
  • Sweden
  • Type 2 Diabetes
  • Diabetes
  • Broker research
  • Company
  • Drug Approval
  • Diabetes Prevalence
View report >

Medtronic Investor presentation

  • December 2021
  • 6 pages
  • United States
  • Ireland
  • Diabetes
  • Medical Supply
  • Investor presentation
  • Company
View report >

BioCardia Analyst report

  • December 2021
  • 4 pages
  • United States
  • European Union
  • Cell Therapy
  • Heart Failure
  • Broker research
  • Company
View report >

Can-Fite BioPharma Analyst report

  • December 2021
  • 6 pages
  • United States
  • World
  • Pharmaceutical
  • Pathology
  • Broker research
  • Company
View report >

GSK Analyst report

  • December 2021
  • 13 pages
  • India
  • Canada
  • Financial Services
  • Beverage
  • Broker research
  • Company
  • Young Population
View report >

Integrity Applications, Inc. Quarterly report

  • November 2021
  • 15 pages
  • United States
  • World
  • Diabetes
  • Research And Development
  • Quarterly report
  • Company
  • Diabetes Prevalence
  • Property Sales
View report >

Nemaura Medical Quarterly report

  • November 2021
  • 19 pages
  • United Kingdom
  • United States
  • Pharmaceutical
  • Healthcare
  • Quarterly report
  • Company
  • Employment Income
View report >

InspireMD Quarterly report

  • November 2021
  • 20 pages
  • United States
  • World
  • Research And Development
  • Business Services
  • Quarterly report
  • Company
  • Employment Costs
  • Property Sales
View report >

Amphastar Investor presentation

  • November 2021
  • 26 pages
  • United States
  • France
  • Biosimilar
  • Research And Development
  • Investor presentation
  • Company
View report >

Amarin Investor presentation

  • November 2021
  • 23 pages
  • United States
  • World
  • Cardiovascular Disease
  • Statins
  • Investor presentation
  • Company
  • Drug Approval
View report >

Amphastar Investor presentation

  • November 2021
  • 26 pages
  • United States
  • France
  • Biosimilar
  • Research And Development
  • Investor presentation
  • Company
View report >

Vicore Pharma Investor presentation

  • November 2021
  • 31 pages
  • World
  • Europe
  • Respiratory Disease
  • Investor presentation
  • Company
  • Drug Approval
  • Life Expectancy
View report >

Idorsia Company report

  • October 2021
  • 7 pages
  • United States
  • World
  • Hospital
  • Neurological Disorder
  • Company research
  • Company
View report >

Uscom Quarterly report

  • October 2021
  • 8 pages
  • Russia
  • World
  • Heart Failure
  • Cardiovascular Disease
  • Quarterly report
  • Company
View report >

Galapagos Investor presentation

  • October 2021
  • 34 pages
  • Europe
  • Renal Disease
  • Investor presentation
  • Company
View report >

Uscom Quarterly report

  • October 2021
  • 9 pages
  • World
  • Russia
  • Heart Failure
  • Cardiovascular Disease
  • Quarterly report
  • Company
View report >

DBV Technologies Quarterly report

  • September 2021
  • 7 pages
  • France
  • World
  • Food Allergy
  • Clinical Trial
  • Quarterly report
  • Company
View report >

Kancera AB Half year report

  • September 2021
  • 22 pages
  • European Union
  • Drug Development
  • Clinical Trial
  • Interim report
  • Company
  • Number Of Employees
View report >

Nexstim Investor presentation

  • September 2021
  • 11 pages
  • World
  • United States
  • Diagnostics
  • Healthcare
  • Investor presentation
  • Company
View report >

Auris Medical Investor presentation

  • September 2021
  • 14 pages
  • United States
  • Europe
  • Allergy
  • Clinical Development
  • Investor presentation
  • Company
  • Mortality Rate
View report >

Allergy Therapeutics Annual report

  • September 2021
  • 28 pages
  • Europe
  • World
  • Pharmaceutical
  • Therapy
  • Annual report
  • Company
  • Greenhouse Gas Emissions
View report >

Allergy Therapeutics Annual report

  • September 2021
  • 22 pages
  • Europe
  • World
  • Pharmaceutical
  • Allergy
  • Annual report
  • Company
  • Greenhouse Gas Emissions
View report >

Santhera Pharmaceuticals Quarterly report

  • September 2021
  • 5 pages
  • United States
  • North America
  • Private Placement
  • Respiratory Disease
  • Quarterly report
  • Company
View report >

CARMAT Analyst report

  • September 2021
  • 5 pages
  • Europe
  • United States
  • Financial Services
  • Heart Failure
  • Broker research
  • Company
View report >

Mayo Clinic Investor presentation

  • September 2021
  • 16 pages
  • World
  • United States
  • Heart Failure
  • Investor presentation
  • Company
  • Electronic Component Production
  • Drug Approval
View report >

Voluntis Quarterly report

  • September 2021
  • 5 pages
  • France
  • United States
  • Therapy
  • Chronic Disease
  • Quarterly report
  • Company
61 reports

Purchase Reports From Reputable Market Research Publishers

Grifols SA (GRF) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • December 2021
  • 75 pages

Summary Grifols SA (Grifols) is a pharmaceutical and chemical manufacturer that focuses on enhancing the health and well-being of people around the world.It conducts research, development, manufacturing ...

  • World
  • United States
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Company research
  • Company
  • Biologics Sales
  • Drug Approval

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on